American Health and Drug Benefits
Scope & Guideline
Enhancing understanding of health management in the pharmaceutical landscape.
Introduction
Aims and Scopes
- Healthcare Economics:
The journal emphasizes research on the economic aspects of healthcare, including cost-effectiveness analyses and budget impact assessments for medications and treatments. - Drug Utilization and Management:
It covers studies related to the utilization patterns of drugs, including opioid management and medication therapy management, highlighting strategies to optimize drug use. - Chronic Disease Management:
The journal frequently publishes articles addressing the management of chronic diseases, including cancer and COPD, focusing on treatment patterns and healthcare costs. - Health Disparities:
Research on health disparities, particularly in medication adherence and access to care among different racial and ethnic groups, is a critical area of focus. - Policy and Innovation in Healthcare:
It explores policy implications and innovative approaches in healthcare delivery, particularly regarding the implementation of biosimilars and the impact of Medicare policies.
Trending and Emerging
- Real-World Evidence in Treatment Patterns:
There is an increasing emphasis on real-world studies that analyze treatment patterns and healthcare costs, particularly in chronic conditions, which helps inform policy and practice. - Cost-Effectiveness Analyses:
Recent publications highlight a growing interest in cost-effectiveness studies for various treatments, signaling a trend towards evidence-based economic evaluations in healthcare. - Integration of Biosimilars in Healthcare:
The implementation strategies for biosimilars are gaining traction, reflecting a broader trend towards innovative treatment options and cost-containment strategies in the pharmaceutical sector. - Addressing Racial and Ethnic Disparities:
Research focusing on reducing health disparities, especially through Medicare Part D and medication management, is increasingly relevant, highlighting a commitment to equity in healthcare access. - Impact of COVID-19 on Healthcare Practices:
The effects of the COVID-19 pandemic on medication adherence and healthcare delivery models are emerging themes, indicating a response to the changing landscape of healthcare.
Declining or Waning
- Mental Health in Workplace Settings:
Topics related to mental illness disclosure and workplace improvements have become less frequent, indicating a potential waning interest in this area within the journal's focus. - Historical Perspectives on Healthcare:
The exploration of historical narratives, such as the 'Government, Big Pharma, and the People' series, appears to be diminishing, suggesting a shift towards more contemporary issues. - General Health Promotion Among College Students:
Research specifically targeting health promotion and prescription drug misuse among college students seems to be less prevalent, indicating a decrease in focus on this demographic.
Similar Journals
European Journal of Hospital Pharmacy
Fostering Knowledge for Enhanced Patient CareThe European Journal of Hospital Pharmacy, published by the prestigious BMJ PUBLISHING GROUP, stands as a vital resource in the field of pharmacy, specifically focused on practices within hospital settings. With its ISSN 2047-9956 and E-ISSN 2047-9964, this journal provides an essential platform for researchers, practitioners, and students to disseminate and access high-quality research that influences clinical practice. Recognized for its significant impact, the journal has achieved a commendable Q2 ranking in both the Pharmacology, Toxicology and Pharmaceutics (miscellaneous) and Pharmacy categories according to Scopus, highlighting its status within the academic community. The journal is indexed among the top 18% in its category, showcasing innovative research and advancements in the field. While the European Journal of Hospital Pharmacy does not operate under an open-access model, its deep commitment to enhancing pharmaceutical care within European hospital settings remains undeterred. The journal also covers a converged period from 2010 to 2024, providing comprehensive insights into evolving practices and challenges. As a premier publication, it plays an essential role in education and professional development, making it indispensable for those involved in pharmacy and healthcare.
Primary Care Diabetes
Cultivating knowledge for a healthier future in diabetes management.Primary Care Diabetes is a leading journal published by ELSEVIER SCI LTD, focusing on the intersection of diabetes care, endocrinology, and family medicine. Since its inception in 2007, the journal has made significant contributions to the field, achieving notable rankings in various categories, such as Q2 in Endocrinology, Diabetes and Metabolism, Q1 in Family Practice, and Q2 in Internal Medicine, as well as Nutrition and Dietetics for 2023. With an ISSN of 1751-9918 and an E-ISSN of 1878-0210, it serves as an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practice in primary diabetes care. The journal's strong Scopus rankings reflect its commitment to publish high-quality research, fostering clinical practice improvements and enhanced patient outcomes. Although not open access, its articles are pivotal for anyone looking to stay ahead in the dynamic and vital domain of diabetes management.
Health Services Research and Managerial Epidemiology
Bridging research and practice for better health outcomes.Health Services Research and Managerial Epidemiology is an esteemed peer-reviewed journal published by SAGE Publications Inc, dedicated to advancing the fields of health services research and epidemiology. With the ISSN 2333-3928, this Open Access journal, available since 2014, aims to foster a deeper understanding of the managerial aspects of epidemiology and its implications for health service delivery. By offering insights into critical healthcare policies and practices, the journal serves as an important resource for researchers, practitioners, and students alike. As of 2023, it is classified in the Q3 quartile for both Epidemiology and Health Policy, ranking within the 31st and 30th percentiles, respectively, in Scopus rankings. The journal’s scope encompasses a wide variety of topics, ranging from health management practices to innovative research methodologies, making it a key platform for disseminating influential work that shapes health policy and public health strategies. Operating out of the United States, at 2455 Teller Rd, Thousand Oaks, CA 91320, it continues to push the boundaries of knowledge in an increasingly vital area of study.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Exploring the frontiers of clinical pharmacy and therapeutics.JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
Elevating health management through cutting-edge research.American Journal of Health-System Pharmacy, published by Oxford University Press Inc., stands as a vital resource in the domains of pharmacy and health policy. With an ISSN of 1079-2082 and E-ISSN 1535-2900, this esteemed journal provides a platform for disseminating high-quality research and insights that influence the practice of pharmacy and health management. The journal boasts a Q1 ranking in Pharmacy and ranks within the top quartiles in Health Policy and Medicine, reflecting its substantial impact on the field. With a comprehensive focus extending from 1995 to 2024, it caters to a diverse audience, including health professionals, researchers, and students interested in the ever-evolving dynamics of health-system pharmacy. Although it does not offer Open Access, the journal ensures that subscribers gain access to cutting-edge research essential for advancing health implications in pharmacy practice. By prioritizing innovative studies and reviews, the American Journal of Health-System Pharmacy plays a crucial role in shaping effective pharmaceutical care strategies and policies.
Journal of Managed Care & Specialty Pharmacy
Shaping Health Policy with Impactful InsightsThe Journal of Managed Care & Specialty Pharmacy is a premier publication in the realm of health policy and pharmaceutical science, dedicated to enhancing the understanding and practices surrounding managed care systems and specialty medications. Published by ACAD MANAGED CARE PHARMACY, this journal boasts an impressive Q1 ranking in both Pharmaceutical Science and Pharmacy, underscoring its significance in advancing professional discourse and research in these critical areas. With a focus on innovative care strategies and patient-centered approaches, it aims to share impactful research, reviews, and opinions that shape the future of health policy and pharmaceutical practices. The journal is available in an open access format, ensuring that vital information is universally accessible to researchers, practitioners, and policymakers alike. With its inception in 2014 and an ongoing commitment to excellence through 2024, the journal is firmly established as a leading resource within its field, making it essential reading for professionals dedicated to improving managed care and specialty pharmacy solutions.
Journal of the American College of Clinical Pharmacy
Transforming pharmacy practice through scholarly excellence.Welcome to the Journal of the American College of Clinical Pharmacy, a distinguished publication in the field of pharmacy and related health professions, published by WILEY since 2018. With a strong commitment to advancing clinical pharmacy practices, this journal serves as a vital resource for researchers, professionals, and students seeking to stay at the forefront of pharmaceutical science. Boasting impressive category quartiles, including Q2 in Pharmaceutical Science and Pharmacy, alongside a notable Scopus ranking in Health Professions and Pharmacology, it stands as a key platform for disseminating cutting-edge research and innovative approaches in clinical pharmacy. Although this journal maintains a subscription-based model, its rigorous peer review process and emphasis on high-quality research ensure that it continues to make significant contributions to the field. Join us in exploring the latest insights and developments from a community dedicated to improving patient care and health outcomes.
Pharmacy Practice-Granada
Empowering pharmacy practice through innovative research.Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.
Journal of the American Board of Family Medicine
Fostering Innovation and Excellence in Family Healthcare.The Journal of the American Board of Family Medicine, with ISSN 1557-2625 and E-ISSN 1558-7118, is a prestigious publication dedicated to advancing the field of family medicine. Published by the American Board of Family Medicine, this journal has established itself as a vital resource for researchers, practitioners, and students interested in both family practice and public health. As of 2023, it boasts impressive rankings, being in the Q1 category of Family Practice and the Q2 category of Public Health, Environmental and Occupational Health according to Scopus metrics, reflecting its significant impact and influence in the academic community. The journal's focus on high-quality research ensures that it remains at the forefront of evidence-based practice, fostering the dissemination of knowledge that is critical for improving patient care and outcomes. This journal, although not open-access, provides a wealth of insights and findings relevant to professionals striving to enhance their understanding and implementation of best practices in family medicine. With a converged publication history starting in 2002, it continues to serve as an essential platform for innovative studies and discussions that shape the future of family medicine.
HOSPITAL PHARMACY
Catalyzing advancements in pharmacy for enhanced patient outcomes.Hospital Pharmacy is a distinguished journal published by SAGE Publications Inc., dedicated to advancing the field of pharmacy practice within health professions. Established in 1973 and with a commitment to scholarly excellence extending to 2024, the journal aims to provide a platform for research that impacts patient care and medication management. With an impact factor that reflects its contribution to the field, it holds a notable position in Pharmacology and Pharmacy, ranking in the Q3 category in both pharmacology domains and Q2 in the pharmacy category as of 2023. The journal’s commitment to evidence-based practice is evident through its rigorous publication standards, making it an essential resource for researchers, practitioners, and students alike. Though it operates under a subscription model, its vast repository of knowledge facilitates significant advancements in pharmaceutical sciences and clinical pharmacy practices. For those engaged in the healthcare sector, Hospital Pharmacy serves not only as a source of research but also as a catalyst for innovative practices in the pharmacy profession.